Atlas Trials

Sumithira Vasu

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sumithira Vasu

RecordFirmDate
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies (NCT05418088)Sumithira Vasu2022-06-30
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT (NCT03665675)Sumithira Vasu2020-11-07
Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML (NCT04220684)Sumithira Vasu2020-06-11
Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant (NCT03537599)Sumithira Vasu2020-01-10

Track Sumithira Vasu automatically

Every clearance here is in the API, with alerts when new ones post.